-
Loading metrics
Open Access
Peer-reviewed
Research Article
High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer
-
Chotaro Onaga,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Shoma Tamori,
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Izumi Matsuoka,
Roles Formal analysis, Investigation, Validation, Visualization, Writing – review & editing
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Ayaka Ozaki,
Roles Funding acquisition, Investigation, Writing – review & editing
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Hitomi Motomura,
Roles Funding acquisition, Investigation, Writing – review & editing
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Yuka Nagashima,
Roles Validation
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Tsugumichi Sato,
Roles Methodology, Validation, Writing – review & editing
Affiliation Department of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Keiko Sato,
Roles Methodology, Validation, Writing – review & editing
Affiliation Department of Information Sciences, Faculty of Sciences and Technology, Tokyo University of Science, Chiba, Japan
⨯ -
Yuyun Xiong,
Roles Validation, Writing – review & editing
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯ -
Kazunori Sasaki,
Roles Investigation, Validation, Writing – review & editing
Affiliation Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo, Japan
⨯ -
Shigeo Ohno,
Roles Funding acquisition, Writing – review & editing
Affiliation Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo, Japan
⨯ -
Kazunori Akimoto
Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: akimoto@rs.tus.ac.jp
Affiliation Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan
⨯
High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer
- Chotaro Onaga,
- Shoma Tamori,
- Izumi Matsuoka,
- Ayaka Ozaki,
- Hitomi Motomura,
- Yuka Nagashima,
- Tsugumichi Sato,
- Keiko Sato,
- Yuyun Xiong,
- Kazunori Sasaki
- Published: May 23, 2022
- https://doi.org/10.1371/journal.pone.0268799